Fig. 5From: PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracilPPARG activation increases chemotherapy sensitivity of 5-Fluorouracil. Dose-response-curves for 5-Fluorouracil in cell lines HT29 and SW403 after treatment with the PPARG agonists pioglitazone and rosiglitazone, as well as the PPARG inhibitor GW9662 (statistical test results are shown in Table 3)Back to article page